News from

Medicine

Reset All Filters
1628 Results
CAR T-cell therapy could help prevent clogged arteries
New Scientist

CAR T-cell therapy could help prevent clogged arteries

Robert Schwab of the Perelman School of Medicine says that, if statins worked perfectly, cardiovascular disease wouldn’t remain the leading cause of death worldwide.

No evidence that CAR T cell therapy causes secondary cancers
Person in gloves holding a medical bag of liquids.

Image: Courtesy of Penn Medicine

No evidence that CAR T cell therapy causes secondary cancers

In a new study, researchers at Penn Medicine looked for—and did not find—examples where the process of generating CAR T cells caused malignancy.

Kelsey Geesler

Standardizing provider assessments to aid veterans at risk of suicide
An Army veteran speaking with a medical professional.

Image: iStock/Drazen Zigic

Standardizing provider assessments to aid veterans at risk of suicide

A Penn Medicine study of nearly 39,000 health records is the first to examine access to firearms and opioids, and completion of related interventions, among veterans at risk for suicide receiving care at the VA.

Eric Horvath

The compassionate team behind CAR T cancer breakthroughs
From left, research coordinator Nicolas Sarmiento, project manager Reenie Martins, research coordinator Lee Dengel, and trial sample coordinator Rutendo Manyeka in a hospital.

(From left) Research coordinator Nicolas Sarmiento, project manager Reenie Martins, research coordinator Lee Dengel, and trial sample coordinator Rutendo Manyeka document and prepare paperwork required for T-cell infusion.

(Image: Courtesy of Penn Medicine News)

The compassionate team behind CAR T cancer breakthroughs

The clinical trial support staff at Penn Medicine and the Abramson Cancer Center have helped execute the team science that brings research discoveries from the lab bench to the bedside.

From Penn Medicine News

Scientists create tiny anticancer weapons that make tumors destroy themselves
Interesting Engineering

Scientists create tiny anticancer weapons that make tumors destroy themselves

Xiaowei (George) Xu of the Perelman School of Medicine and colleagues have unveiled an innovative approach to cancer treatment that leverages tiny capsules known as small extracellular vesicles to target a specific receptor on tumor cells.

The motor driving Penn’s biomedical research
Michael Ostap

Michael Ostap is the interim senior vice dean and chief scientific officer of the Perelman School of Medicine.

(Image: Courtesy of Penn Medicine Magazine)

The motor driving Penn’s biomedical research

For nearly three decades, interim senior vice dean and chief scientific officer of the Perelman School of Medicine Michael Ostap has investigated how molecules such as myosin feel force, in an effort to understand how cellular mutations cause disease.

Meredith Lidard Kleeman for Penn Medicine Magazine

Science behind genetic testing for identifying risk of opioid misuse remains unproven
A scientist with a pipette and a test tube with a computer screen in the background.

Image: iStock/Cavan Images

Science behind genetic testing for identifying risk of opioid misuse remains unproven

A new report from researchers at the Perelman School of Medicine and Crescenz VA Medical Center has evaluated a genetic test for opioid use disorder that recently received pre-marketing approval by the FDA, finding that the genes comprising it do not accurately identify individuals likely to develop the disorder.

Eric Horvath